|Home|
« Surgical solutions for acid reflux - Nashua Telegraph
Acid-reflux sufferers should avoid 'trigger' foods - Tulsa World »

If you're new here, you may want to subscribe to my RSS feed. Thanks for visiting!

AstraZeneca profit beats forecasts, shares up
Healthcare Digital, UK - 12 hours ago
Its acid reflux drug Nexium is also experiencing slower revenues as it beats off competition from cheaper rivals. Anti-cholesterol treatment Crestor, …

Source:AstraZeneca profit beats forecasts, shares up - Healthcare Digital

This entry was posted on 1 August 2008 at 12:00 am and is filed under acid reflux. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply